EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Status and Future Directions of Proton Therapy for Head and Neck Carcinoma

Sara Lillo iD, Alfredo Mirandola iD, Alessandro Vai, Anna Maria Camarda, Sara Ronchi iD, Maria Bonora, Rossana Ingargiola iD, Barbara Vischioni iD, Ester Orlandi iD

Cancers · 30.05.2024 · 16 (11) · 2085

DOI: 10.3390/cancers16112085 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 30.05.2024. Verfasst von Sara Lillo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), 27100 Pavia, Italy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The growing interest in proton therapy (PT) in recent decades is justified by the evidence that protons dose distribution allows maximal dose release at the tumor depth followed by sharp distal dose fall-off. But, in the holistic management of head and neck cancer (HNC), limiting the potential of PT to a mere dosimetric advantage appears reductive. Indeed, the precise targeting of PT may help evaluate the effectiveness of de-escalation strategies, especially for patients with human papillomavirus associated-oropharyngeal cancer (OPC) and nasopharyngeal cancer (NPC). Furthermore, PT could have potentially greater immunogenic effects than conventional photon therapy, possibly enhancing both the radiotherapy (RT) capability to activate anti-tumor immune response and the effectiveness of immunotherapy drugs. Based on these premises, the aim of the present paper is to conduct a narrative review reporting the safety and efficacy of PT compared to photon RT focusing on NPC and OPC. We also provide a snapshot of ongoing clinical trials comparing PT with photon RT for these two clinical scenarios. Finally, we discuss new insights that may further develop clinical research on PT for HNC.

Schlagwörter

Stichwörter der Autor:innen

future directionshead and neck cancernasopharyngeal canceroropharyngeal cancerproton therapy

Autor:innen und Institutionen

  • Radiation Oncology Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), 27100 Pavia, Italy.
  • Medical Physics Unit, Clinical Department, National Center for Oncological Hadrontherapy (CNAO), 27100 Pavia, Italy.
  • Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.

ORCID-Profile: Sara Lillo, Alfredo Mirandola, Sara Ronchi, Rossana Ingargiola, Barbara Vischioni, Ester Orlandi

Zitieren

APA

Lillo, S., Mirandola, A., Vai, A., Camarda, A. M., Ronchi, S., Bonora, M., Ingargiola, R., Vischioni, B., & Orlandi, E. (2024). Current Status and Future Directions of Proton Therapy for Head and Neck Carcinoma. Cancers, 16(11), 2085. https://doi.org/10.3390/cancers16112085

Vancouver

Lillo S, Mirandola A, Vai A, Camarda AM, Ronchi S, Bonora M, et al. Current Status and Future Directions of Proton Therapy for Head and Neck Carcinoma. Cancers. 2024;16(11):2085. doi:10.3390/cancers16112085

BibTeX
@article{Lillo2024,
  author = {Lillo, Sara and Mirandola, Alfredo and Vai, Alessandro and Camarda, Anna Maria and Ronchi, Sara and Bonora, Maria and Ingargiola, Rossana and Vischioni, Barbara and Orlandi, Ester},
  title = {Current Status and Future Directions of Proton Therapy for Head and Neck Carcinoma},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {11},
  pages = {2085},
  doi = {10.3390/cancers16112085}
}
Kostenlos starten →